FindTrial
Sign In

FSH-promoted NE secretion plays an important role in the development of vasofunctional disturbances in perimenopause

FSH-promoted NE secretion plays an important role in the development of vasofunctional disturbances

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-CCS-14004906
Enrollment
Unknown
Registered
2014-04-18
Start date
2012-08-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

vasofunctional disturbances in peri- and post- menopause

Interventions

Case series:N/A

Sponsors

Women Hospital, College of Medicine, Zhejiang University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
25 Years to 60 Years

Inclusion criteria

Inclusion criteria: according to STRAW+10,200 women in perimenopause were included.

Exclusion criteria

Exclusion criteria: cluding non-physiological aging (such as premature ovarian failure, surgical castration or chemotherapy-induced senescence, etc.), hypothalamic - pituitary - ovarian / thyroid / adrenal tumors or disease, as hypothalamic amenorrhea, PCOS, etc.. Participatants in the study signed an informed consent form.

Design outcomes

Primary

MeasureTime frame
Norepinephrine;dopamine;epinephrin;—

Countries

China

Contacts

Public ContactHuang He-feng
huanghefg@hotmail.com+86 0571-88208804

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026